Inhibition Effects of Compatibility of Astragali Radix and Curcumae Rhizoma and Combination with Cisplatin on Orthotopic Tumor in Nude Mice Bearing Human Hepatocellular Carcinoma

ZANG Wen-hua; TANG De-cai; YIN Gang; LI Bing-bing

doi:10.11653/syfj2014050131

您当前的位置：

首页 >

文章列表页 >

Inhibition Effects of Compatibility of Astragali Radix and Curcumae Rhizoma and Combination with Cisplatin on Orthotopic Tumor in Nude Mice Bearing Human Hepatocellular Carcinoma

更新时间：2024-01-04

- Inhibition Effects of Compatibility of Astragali Radix and Curcumae Rhizoma and Combination with Cisplatin on Orthotopic Tumor in Nude Mice Bearing Human Hepatocellular Carcinoma
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 5, Pages: 131-136(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2014050131
  CLC：
- Published：2014
- 稿件说明：
移动端阅览
ZANG Wen-hua, TANG De-cai, YIN Gang, et al. Inhibition Effects of Compatibility of Astragali Radix and Curcumae Rhizoma and Combination with Cisplatin on Orthotopic Tumor in Nude Mice Bearing Human Hepatocellular Carcinoma[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(5): 131-136.
DOI：

ZANG Wen-hua, TANG De-cai, YIN Gang, et al. Inhibition Effects of Compatibility of Astragali Radix and Curcumae Rhizoma and Combination with Cisplatin on Orthotopic Tumor in Nude Mice Bearing Human Hepatocellular Carcinoma[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(5): 131-136. DOI： 10.11653/syfj2014050131.

摘要

目的：探讨补气活血药黄芪-莪术配伍以及联合顺铂（DDP）对人肝癌裸鼠原位移植瘤生长的抑制作用。方法：构建人肝癌裸鼠原位移植瘤模型。成瘤后，将其随机分为8组：模型对照组、阳性对照组（DDP 2 mg·kg-1，ip）、黄芪-莪术配伍高剂量组（H，12 g·kg-1·d-1，ig）、黄芪-莪术配伍中剂量组（M，6 g·kg-1·d-1，ig）、黄芪-莪术配伍低剂量组（L，3 g·kg-1·d-1，ig）、黄芪-莪术配伍高剂量+顺铂组（H+DDP）、黄芪-莪术配伍中剂量+顺铂组（M+DDP）、黄芪-莪术配伍低剂量+顺铂组（L+DDP），每组8只。观察黄芪-莪术配伍对原位移植瘤的作用及与DDP合用的效果；免疫组化SP法检测肿瘤组织缺氧诱导因子-1α（HIF-1α）、血管内皮生长因子（VEGF）的表达。结果：黄芪-莪术配伍H，M，L组的平均瘤重分别为（1.28±0.21），（1.61±0.28），（1.65±0.27）g，平均瘤体积分别为（1 065.42±275.63），（1 398.77±358.75），（1 419.28±405.17）mm3，均低于模型对照组的平均瘤重（2.19±0.30）g及平均瘤体积（1 866.21±433.49）mm3（P<0.05，P<0.01）；H+DDP，M+DDP，L+DDP的平均瘤重分别为（0.48±0.19），（0.83±0.29），（1.01±0.31）g，平均瘤体积分别为（381.86±273.14），（704.09±386.52），（827.75±424.58）mm3，均低于DDP组，H+DDP组有显著性差异（P<0.05）。免疫组化结果提示，黄芪-莪术配伍H，M，L，H+DDP，M+DDP，L+DDP各组HIF-1α，VEGF阳性表达强度均下降，与模型对照组比较有显著性差异（P<0.05，P<0.01）。结论：黄芪-莪术配伍对人肝癌裸鼠原位移植瘤的生长有抑制作用，且抑制作用与剂量有一定的正相关性，其机制可能与对HIF-1α，VEGF表达的抑制有关，与DDP合用表现为协同增效和相加作用。

Abstract

Objective: To study the anti-tumor effects of Astragali Radix and Curcumae Rhizoma on the growth of transplanted human hepatocarcinoma in nude mice and its combinative effect with cisplatin(DDP). Method: Human hepatocarcinoma cells HepG2 were transplanted into nude mice to form the model

and the modeled mice were divided at random into 8 groups:model group

cisplatin(DDP) group (intraperitoneal injection with 2 mg·kg-1 DDP)

high dosage of Astragali Radix and Curcumae Rhisoma (H)(intragastric administration with 12 g·kg-1·d-1 physic liquor)

intermediate dosage of Astragali Radix and Curcumae Rhizoma (M) (intragastric administration with 6 g·kg-1·d-1physic liquor)

low dosage of Astragali Radix and Curcumae Rhizoma (L) (intragastric administration with 3 g·kg-1·d-1 physic liquor)

high dosage and cisplatin group(H+DDP)

intermediate dosage and cisplatin group(M+DDP)

low dosage and cisplatin group(L+DDP)

8 in each group. The effect of Astragali Radix and Curcumae Rhizoma on Transplantation tumor and combinative effect with DDP were observed. Expressions of hypoxia inducible factor-1α (HIF-1α) and Wascular endothelial growth factor (VEGF) protein in transplantation tumors were determined by immunohisto chemical method with an image analysis system. Result: The tumor weight and volume were (1.28±0.21)g and (1 065.42±275.63)mm3 in H

(1.61±0.28)g and (1 398.77±358.75)mm3 in M

(1.65±0.27)g and (1 419.28±405.17)mm3 in L

all significantly lower than those in model group (2.19±0.30)g and (1 866.21±433.49)mm3

(P<0.05

P<0.01). The tumor weight and volume were (0.48±0.19)g and (381.86±273.14)mm3 in H+DDP

(0.83±0.29)g and (704.09±386.52)mm3 in M+DDP

(1.01±0.31)g and (827.75±424.58)mm3 in L+DDP.H+DDP group was significantly lower than DDP group(P<0.05). Contrary to the model group

expressions of HIF-1α and VEGF protein were significantly down-regulated by H

H+DDP

M+DDP and L+DDP group(P<0.05

P<0.01). Conclusion: Astragali Radix and Curcumae Rhizoma can inhibit the growth of human hepatocarcinoma in nude mice and the inhibition effect was positive correlation with dosage. The combination of Astragali Radix

Curcumae Rhizoma and DDP showed synergistic action and additive chemotherapeutic effect.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Astragali Radix-Curcumae Rhizoma and Combined with Cisplatin on Apoptosis of Hepatocellular Carcinoma Cells and Expressions of miR-122a, miR-221 and miR-151

Screening of Antidepressant Active Components from Curcumae Rhizoma and Its Mechanism in Regulating Nrf2/GPX4/GSH Pathway

Investigation of Component Difference of Astragali Radix Before and After Rice Stir-frying by UPLC-Q-TOF-MS/MS Combined with Chemometrics

Compound Xishu Granules Inhibit Proliferation of Hepatocellular Carcinoma Cells by Regulating Ferroptosis

Clinical Efficacy of Modified Huangqi Chifengtang in Treatment of IgA Nephropathy Patients and Exploration of Dose-effect Relationship of Astragali Radix

Related Author

HUANG Xian-zhang

SONG Yonggui

DUAN Delin

LAI Meixizi

LIU Yali

AI Zhifu

ZHU Genhua

XU Huanhua

Related Institution

Key Laboratory of Depression Animal Model Based on Traditional Chinese Medicine（TCM）Syndrome of Jiangxi Province Administration of TCM，Key Research Office for Evaluation of TCM Efficacy（Prevention and Treatment of Mental Disorders and Brain Diseases） of Jiangxi Province Administration of TCM， Jiangxi University of Chinese Medicine

Key Laboratory of Pharmacodynamics and Safety Evaluation，Health Commission of Jiangxi Province，Nanchang Medical College

Jiangxi Guxiang Jinyun Comprehensive Health Industry Co. Ltd.

Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine

Nanjing Women and Children's Healthcare Hospital

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰